ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

NCT05507203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

639

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: ABX464
DRUG: Placebo

Sponsor

Abivax S.A.